Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 133 citing articles:

Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies
Eleonora Calzoni, Alessio Cesaretti, Alice Polchi, et al.
Journal of Functional Biomaterials (2019) Vol. 10, Iss. 1, pp. 4-4
Open Access | Times Cited: 392
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Weisen Zhang, Ami Mehta, Ziqiu Tong, et al.
Advanced Science (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 288
<p>Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders</p>
Hanie Yavarpour‐Bali, Maryam Ghasemi‐Kasman, Marzieh Pirzadeh
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 4449-4460
Open Access | Times Cited: 277
Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Ka Hong Wong, Muhammad Kashif Riaz, Yuning Xie, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 381-381
Open Access | Times Cited: 173
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
Garima Sharma, Ashish Ranjan Sharma, Sang‐Soo Lee, et al.
International Journal of Pharmaceutics (2019) Vol. 559, pp. 360-372
Closed Access | Times Cited: 162
Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Bahare Salehi, Daniela Călina, Anca Oana Docea, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 430-430
Open Access | Times Cited: 162
Formulations of Curcumin Nanoparticles for Brain Diseases
Marí­a Luisa Del Prado-Audelo, Isaac H. Caballero‐Florán, Jorge A. Meza-Toledo, et al.
Biomolecules (2019) Vol. 9, Iss. 2, pp. 56-56
Open Access | Times Cited: 155
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
Mazen M. El‐Hammadi, José L. Arias
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 354-354
Open Access | Times Cited: 80
Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
Attilio Marino, Matteo Battaglini, Nadia Moles, et al.
ACS Omega (2022) Vol. 7, Iss. 30, pp. 25974-25990
Open Access | Times Cited: 71
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Chih Hung Lo, Jialiu Zeng
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 19
Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases
Mitra Pirhaghi, Fatemeh Mamashli, Faezeh Moosavi-Movahedi, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2097-2117
Closed Access | Times Cited: 17
Erythrocyte membrane-coated nanocarriers modified by TGN for Alzheimer's disease
Jinlian Gu, Chang Yan, Shun Yin, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 448-459
Closed Access | Times Cited: 16
Curcumin, Hormesis and the Nervous System
Maria Scuto, Cesare Mancuso, Barbara Tomasello, et al.
Nutrients (2019) Vol. 11, Iss. 10, pp. 2417-2417
Open Access | Times Cited: 142
Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice
Chunhong Gao, Yuli Wang, Jiejie Sun, et al.
Acta Biomaterialia (2020) Vol. 108, pp. 285-299
Closed Access | Times Cited: 114
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, et al.
Biomedicines (2020) Vol. 8, Iss. 1, pp. 13-13
Open Access | Times Cited: 110
Neuroprotection by curcumin: A review on brain delivery strategies
Anis Askarizadeh, George E. Barreto, Neil C. Henney, et al.
International Journal of Pharmaceutics (2020) Vol. 585, pp. 119476-119476
Closed Access | Times Cited: 86
Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damage
María Pascual, Maria Calvo‐Rodriguez, Lucı́a Núñez, et al.
IUBMB Life (2021) Vol. 73, Iss. 7, pp. 900-915
Open Access | Times Cited: 77
Attenuation of Nrf2/Keap1/ARE in Alzheimer’s Disease by Plant Secondary Metabolites: A Mechanistic Review
Sajad Fakhri, Mirko Pesce, Antonia Patruno, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 4926-4926
Open Access | Times Cited: 74
Curcumin nanoformulations to combat aging-related diseases
Maryam Mahjoob, Ursula Stochaj
Ageing Research Reviews (2021) Vol. 69, pp. 101364-101364
Closed Access | Times Cited: 69
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Duygu Ege
Materials (2021) Vol. 14, Iss. 12, pp. 3332-3332
Open Access | Times Cited: 61
Recent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation
Zhiyuan Ma, Baicheng Li, Jie Peng, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 434-434
Open Access | Times Cited: 61
Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease
Kang Qian, Xiaoyan Bao, Yixian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11455-11472
Closed Access | Times Cited: 57
Enhancement of blood–brain barrier penetration and the neuroprotective effect of resveratrol
Nikita Katila, Ramesh Duwa, Sunil Bhurtel, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 1-19
Closed Access | Times Cited: 56
Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform
Miguel Pinto, Vera Silva, Sandra Barreiro, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101658-101658
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top